Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency

Pediatr Transplant. 2013 Feb;17(1):E29-32. doi: 10.1111/j.1399-3046.2012.01762.x. Epub 2012 Jul 17.

Abstract

In this case report, we describe successful BMT with RIC in a patient with delayed-onset ADA deficiency. A three-yr-old Japanese boy was diagnosed with delayed-onset ADA deficiency because of recurrent bronchitis, bronchiectasia, and lymphopenia. In addition, autoimmune thyroiditis and neutropenia were present. At four yr of age, he underwent BMT with a RIC regimen, including busulfan and fludarabine, from an HLA-identical healthy sister. Engraftment after BMT was uneventful without GVHD. Decreased ADA levels in blood immediately increased following BMT, and the patient was disease-free 13 months after BMT. These results suggest that BMT with RIC may sufficiently restore immune regulation in delayed-onset ADA deficiency. A longer follow-up period is needed to confirm these observations.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / deficiency*
  • Adenosine Deaminase / immunology
  • Agammaglobulinemia / immunology
  • Agammaglobulinemia / therapy*
  • Bone Marrow Transplantation / methods*
  • Busulfan / administration & dosage
  • Child, Preschool
  • Humans
  • Living Donors
  • Male
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / therapy*
  • Time Factors
  • Transplantation Conditioning / methods*
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Adenosine Deaminase
  • Vidarabine
  • Busulfan
  • fludarabine

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency